CD163+ TAM, which have similar properties to M2 macrophages, are associated with an immunosuppressive microenvironment and unfavorable clinical outcomes in breast, bladder, ovarian, gastric, and prostate cancers (47–49). The gene discussed is CD163; the disease is Familial prostate cancer.